Jo H. M. Berden

11.1k citations

176 papers · 7.8k indexed · h-index 54

Immunology top 0.5%
Rheumatology top 0.2%
Nephrology top 0.1%
Molecular Biology top 5%
Cell Biology top 1%

Co-authors: Johan van der Vlag Angelique L. Rops Marinka A.H. Bakker Henry Dijkman Jürgen Dieker Toin H. Van Kuppevelt Jack F.M. Wetzels W.J.M. Tax
Topics: Systemic Lupus Erythematosus Research (58 papers)Renal Diseases and Glomerulopathies (50 papers)Proteoglycans and glycosaminoglycans research (41 papers)
Cited by: Nephrology Rheumatology Immunology
Journals: The Lancet Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: Netherlands United States Germany

In The Last Decade

Jo H. M. Berden

176 papers receiving 7.6k citations

Peers

Countries citing papers authored by Jo H. M. Berden

Since Specialization

Citations

This map shows the geographic impact of Jo H. M. Berden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo H. M. Berden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo H. M. Berden more than expected).

Fields of papers citing papers by Jo H. M. Berden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jo H. M. Berden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo H. M. Berden. The network helps show where Jo H. M. Berden may publish in the future.

Co-authorship network of co-authors of Jo H. M. Berden

This figure shows the co-authorship network connecting the top 25 collaborators of Jo H. M. Berden. A scholar is included among the top collaborators of Jo H. M. Berden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jo H. M. Berden. Jo H. M. Berden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Glomerular endothelial glycocalyx-derived heparan sulfate inhibits glomerular leukocyte influx and attenuates experimental glomerulonephritis 2023 ·Frontiers in Molecular Biosciences ·Marissa L. Maciej-Hulme,Jasper J. van Gemst,(unknown),Angelique L. Rops,Jo H. M. Berden,Bart Smeets,I. Jonathan Amster,Ton J. Rabelink,Johan van der Vlag	2
2	Blocking of inflammatory heparan sulfate domains by specific antibodies is not protective in experimental glomerulonephritis 2021 ·PLoS ONE ·Jasper J. van Gemst,(unknown),Angelique L. Rops,Toin H. Van Kuppevelt,Jo H. M. Berden,Markus A. Loeven,Ton J. Rabelink,Bart Smeets,Johan van der Vlag	2
3	Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains 2018 ·PLoS ONE ·Jasper J. van Gemst,(unknown),Angelique L. Rops,Toin H. Van Kuppevelt,Jo H. M. Berden,Ton J. Rabelink,Markus A. Loeven,Johan van der Vlag	12
4	Neutrophil Extracellular Traps Drive Endothelial-to-Mesenchymal Transition 2017 ·Arteriosclerosis Thrombosis and Vascular Biology ·Elmar Pieterse,Nils Rother,Marjolein Garsen,Julia M. Hofstra,Simon C. Satchell,Markus Hoffmann,Markus A. Loeven,Hanneke Knaapen,Olivier W.H. van der Heijden,Jo H. M. Berden,Luuk B. Hilbrands,Johan van der Vlag	196
5	Heparanase Is Essential for the Development of Acute Experimental Glomerulonephritis 2016 ·American Journal Of Pathology ·Marjolein Garsen,Marilen Benner,Henry Dijkman,Toin H. Van Kuppevelt,Jin‐Ping Li,Ton J. Rabelink,Israël Vlodavsky,Jo H. M. Berden,Angelique L. Rops,Michael Elkin,Johan van der Vlag	51
6	Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte 2015 ·The Journal of Pathology ·Marjolein Garsen,(unknown),Angelique L. Rops,(unknown),Toin H. Van Kuppevelt,Ton J. Rabelink,Joost G.J. Hoenderop,Jo H. M. Berden,Tom Nijenhuis,Johan van der Vlag	38
7	Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis. 2014 ·PubMed ·Suzanne Arends,Jo H. M. Berden,Cecile Grootscholten,R. H. W. M. Derksen,Stefan P. Berger,Ruud G.L. de Sévaux,Alexandre E. Voskuyl,(unknown)	9
8	Dutch guidelines for diagnosis and therapy of proliferative lupus nephritis. 2012 ·PubMed ·(unknown),Alexandre E. Voskuyl,Marc Vervloet,Marc Bijl,Ruud G.L. de Sévaux,Stefan P. Berger,R. H. W. M. Derksen,Jo H. M. Berden	18
9	The role of dendritic cells in the pathogenesis of systemic lupus erythematosus 2010 ·Arthritis Research & Therapy ·Justin H. Fransen,Johan van der Vlag,Jurjen M. Ruben,Gosse J. Adema,Jo H. M. Berden,Luuk B. Hilbrands	71
10	Anti-proteinuric effects of glycosaminoglycan-based drugs. 2007 ·PubMed ·Tessa J.M. Wijnhoven,Joost F.M. Lensen,Angelique L. Rops,Kevin McCarthy,Johan van der Vlag,Jo H. M. Berden,Lambert P.W.J. van den Heuvel,Toin H. Van Kuppevelt	15
11	Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains 2007 ·Nephrology Dialysis Transplantation ·(unknown),Joyce Geelen,Marinka A.H. Bakker,Joost F.M. Lensen,Angelique L. Rops,Andrea B. Kramer,G. Navis,(unknown),Johan van der Vlag,Jo H. M. Berden,Jack F.M. Wetzels,Lambert P.W.J. van den Heuvel,L.A.H. Monnens,Toin H. Van Kuppevelt	7
12	Induction of Glomerular Heparanase Expression in Rats with Adriamycin Nephropathy Is Regulated by Reactive Oxygen Species and the Renin-Angiotensin System 2006 ·Journal of the American Society of Nephrology ·Andrea B. Kramer,(unknown),Angelique L. Rops,Tessa J.M. Wijnhoven,Lambert van den Heuvel,Joost F.M. Lensen,Toin van Kuppevelt,Harry van Goor,Johan van der Vlag,Gerjan Navis,Jo H. M. Berden	72
13	Aberrant Heparan Sulfate Profile in the Human Diabetic Kidney Offers New Clues for Therapeutic Glycomimetics 2006 ·American Journal of Kidney Diseases ·Tessa J.M. Wijnhoven,Joost F.M. Lensen,Angelique L. Rops,Johan van der Vlag,Svein O. Kolset,Hans‐Jacob Bangstad,Per Pfeffer,(unknown),Jo H. M. Berden,Lambert P.W.J. van den Heuvel,Toin H. Van Kuppevelt	32
14	Decreased Glomerular Expression of Agrin in Diabetic Nephropathy and Podocytes, Cultured in High Glucose Medium 2001 ·Nephron Experimental Nephrology ·Benito Yard,Stefan Kahlert,(unknown),(unknown),R. Waldherr,Alexander J. Groffen,Lambert P.W.J. van den Heuvel,(unknown),Jo H. M. Berden,Stephan Kröger,(unknown),Fokko J. van der Woude	34
15	Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane 1998 ·Diabetologia ·J.W. van der Pijl,M. R. Daha,Jacob van den Born,Nicole A.M. Verhagen,H. H. P. J. Lemkes,Richard Bucala,Jo H. M. Berden,A. H. Zwinderman,Jan A. Bruijn,Leendert A. van Es,Fokko J. van der Woude	26
16	Altered Composition of Urinary Heparan Sulfate in Patients With COPD 1996 ·American Journal of Respiratory and Critical Care Medicine ·Chris H.A. van de Lest,Elly M. M. Versteeg,J.H. Veerkamp,Jo H. M. Berden,Jacob van den Born,Leo Heunks,J.-W.J. Lammers,C L van Herwaarden,P. N. Richard Dekhuijzen,Toin H. Van Kuppevelt	12
17	Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy 1994 ·Diabetologia ·L.D. Elving,Jack F.M. Wetzels,Henk J.J. van Lier,E. de Nobel,Jo H. M. Berden	40
18	Production and characterization of a monoclonal antibody against human glomerular heparan sulfate. 1991 ·PubMed ·J. van den Born,Lambertus P. van den Heuvel,Marinka A.H. Bakker,J.H. Veerkamp,Karel J.M. Assmann,Jo H. M. Berden	31
19	Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes 1990 ·Journal of Autoimmunity ·Rose-Marie Termaat,Kees Brinkman,F. Van Gompel,Lambert P.W.J. van den Heuvel,Jacques H. Veerkamp,Ruud J.T. Smeenk,Jo H. M. Berden	75
20	Binding of anti-DNA antibodies to glomerular heparan sulfate: a new clue for the pathogenesis of SLE nephritis? 1989 ·PubMed ·Jo H. M. Berden,Rose-Marie Termaat,Kees Brinkman,R J Smeenk,A. J. G. Swaak,P. Faaber,K.J.M. Assmann,(unknown),J.H. Veerkamp	9

About Jo H. M. Berden

Jo H. M. Berden is a scholar working on Nephrology, Immunology and Allergy and Rheumatology, having authored 176 papers that have together received 7.8k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (58 papers), Renal Diseases and Glomerulopathies (50 papers) and Proteoglycans and glycosaminoglycans research (41 papers). The work is most often cited by research in Nephrology (2.3k citations), Rheumatology (2.6k citations) and Immunology (2.8k citations). Jo H. M. Berden has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Johan van der Vlag, Angelique L. Rops, Marinka A.H. Bakker, Henry Dijkman, Jürgen Dieker, Toin H. Van Kuppevelt, Jack F.M. Wetzels, W.J.M. Tax, Mieke C.J. van Bruggen and Karel J.M. Assmann. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact